Anti-Olanzapine (Clone OLA-9251) - 1.0 mg

Primary Monoclonal Antibodies

2 - 8°C Wet Ice

Olanzapine, a second-generation or atypical antipsychotic, is widely used in themanagement of various mental health disorders, including schizophrenia and bipolardisorder. Introduced in the late 20th century, olanzapine exerts its therapeutic effects byantagonizing multiple neurotransmitter receptors, particularly dopamine and serotoninreceptors in the brain. This dual-action helps to modulate the imbalances in theseneurotransmitters associated with psychotic disorders. Olanzapine's method of actionalso involves histamine and alpha-adrenergic receptors blockade, contributing to itsefficacy and potential side effects. Diagnostic testing for olanzapine is not standardpractice, but periodic monitoring may be considered in specific cases for therapeuticdrug monitoring. Blood tests can be utilized to measure olanzapine levels, aidingclinicians in optimizing dosage to achieve optimal symptom control while minimizingadverse effects. This tailored approach to monitoring ensures a personalized andeffective treatment strategy for individuals prescribed olanzapine for various psychiatricconditions.

≥1.0 mg/ml